Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)

计划入组 137 人 · 首次发布于 2018 年 9 月 17 日

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

计划入组 18 人 · 首次发布于 2022 年 10 月 14 日

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

计划入组 17 人 · 首次发布于 2020 年 5 月 12 日

Bladder Cancer(Biomics Biotechnologies)

BCG bladder cancer vaccine (Biofabri)

ZH-9

CATALO NATURALS (AUSTRALIA) PTY LTD

Australia

CENTER WEST CANCER

United States

Orsi Academy

Belgium

Bladder Tumor-Focused Adaptive Radiotherapy: Clinical Outcomes and Feasibility

Phase III BART Trial Shows Adjuvant Radiation Therapy Significantly Reduces Pelvic Recurrence in High-Risk Bladder Cancer

TYRA-300 Shows Promise in FGFR3-Altered Urothelial Carcinoma